Current implications for the managed care of dementia

Area of Science:

• Geriatrics
• Pharmacology
• Health Policy

Background:

• Medicare Part D prescription drug plan changes present significant challenges for physicians managing dementia patients.
• A 2006 survey indicated 70% of physicians experienced difficulties with Medicare Part D, and 28% struggled with dementia medication access.
• Access to dementia medications is crucial, as they can positively impact behavioral symptoms and potentially decrease psychotropic medication use.

Purpose of the Study:

• To address the complexities of Medicare Part D and its impact on dementia patient care.
• To highlight strategies for improving access to antidementia medications in various care settings.
• To discuss appropriate medication use, nonpharmacologic interventions, and patient-centered care in advanced dementia.

Main Methods:

• Review of Medicare Part D complexities and their implications for dementia pharmacotherapy.
• Analysis of strategies for enhancing medication access in nursing homes and assisted living facilities.
• Discussion of appropriate use of cholinesterase inhibitors and glutamate pathway modifiers, alongside nonpharmacologic approaches.

Main Results:

• Physicians report significant difficulties navigating Medicare Part D for dementia medications.
• Effective strategies can improve access to essential antidementia treatments.
• Addressing medication access, patient preferences, and documentation is key to better outcomes.

Conclusions:

• Improving understanding and implementation of Medicare Part D policies is vital for dementia patient care.
• Enhanced access to antidementia medications can lead to better patient outcomes and reduced healthcare expenditures.
• Integrating pharmacologic and nonpharmacologic interventions, alongside end-of-life care considerations, optimizes quality of life for individuals with dementia.